DUBLIN–()–The “US Cannabidiol (CBD) Market (by Types, Distribution Channels & Products): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)” report has been added to ResearchAndMarkets.com’s providing.

The U.S. cannabidiol market is estimated to succeed in US$13.39 billion in 2024, rising at a CAGR of 42.36% for the interval spanning 2020-2024.

The progress of the market has been pushed by a rising incidence of Alzheimer’s illness, upsurge in healthcare expenditure, rising despair fee, growing geriatric inhabitants, mounting on-line retail gross sales and increasing urbanization. However, progress of the market could be challenged by the excessive value of CBD merchandise and unwanted effects related with CBD merchandise.

Some of the noteworthy traits of the market embody growing prevalence of arthritis, rising adoption amongst millennials, the surging prevalence of persistent problems and upswing in sports activities accidents.

The U.S. cannabidiol market is categorized on the premise of sort, distribution channel and product. According to sort, the market can broadly be divided into hemp-derived, marijuana-derived and different pharmaceutical/Epidiolex. On the premise of distribution channels, the U.S. cannabidiol market may be bifurcated into dispensary and retail. Whereas, in phrases of product, the market may be break up into inhalable, confection, sublingual, wellness, magnificence/pores and skin, meals & beverage, dietary supplements, pet care and pharmaceutical.

The Hemp-derived section is the quickest-rising market, owing to the huge progress within the healthcare trade throughout the area, rising quantity of analysis findings and the invention of new therapeutic purposes, enhance in consciousness relating to the advantages of cannabidiol based mostly merchandise, rising utility of cannabidiol in meals, pharma, and cosmetics.

Scope of the Report:

  • The report gives a complete evaluation of the U.S. cannabidiol market segmented on the premise of sort, distribution channel and merchandise.
  • The market dynamics akin to progress drivers, market traits and challenges are analyzed in-depth.
  • The aggressive panorama of the market, alongside with the corporate profiles of main gamers (Aphria Inc., Canopy Growth Corporation, Aurora Cannabis Inc., Charlotte’s Web Holdings Inc., Medical Marijuana, Inc., and CV Sciences Inc.) are additionally offered intimately.

Key Target Audience:

  • Cannabidiol Manufacturers and Suppliers
  • Hemp-Derived Cannabidiol Capsules Manufacturers
  • End Users
  • Research and improvement (R&D) firms
  • Investment Banks
  • Government Bodies & Regulating Authorities

Key Topics Covered:

1. Market Overview

1.1 Introduction

1.2 Classification of Cannabis Plant

1.3 Description of Cannabinoids

1.4 Cannabis Supply Chain

1.5 Health Benefits of Cannabidiol

1.6 Different Types of Cannabidiol Products

1.7 Possible Side Effects of Cannabidiol

2. Impact of COVID-19

2.1 Increasing Cannabidiol (CBD) Usage Rates

2.2 Impact on Cannabidiol Industry

2.3 Sales Hike in Adult Use Cannabis

3. The U.S. Market Analysis

3.1 The U.S. Cannabidiol Market by Value

3.2 The U.S. Cannabidiol Market Forecast by Value

3.3 The U.S. Cannabidiol Market by Type

3.3.1 The U.S. Hemp-Derived Cannabidiol Market by Value

3.3.2 The U.S. Hemp-Derived Cannabidiol Market Forecast by Value

3.3.3 The U.S. Marijuana-Derived Cannabidiol Market by Value

3.3.4 The U.S. Marijuana-Derived Cannabidiol Market Forecast by Value

3.3.5 The U.S. Pharmaceutical/Epidiolex Cannabidiol Market by Value

3.3.6 The U.S. Pharmaceutical/Epidiolex Cannabidiol Market Forecast by Value

3.4 The U.S. Cannabidiol Market by Distribution Channel

3.4.1 The U.S. Dispensary Cannabidiol Market by Value

3.4.2 The U.S. Dispensary Cannabidiol Market Forecast by Value

3.4.3 The U.S. Retail Cannabidiol Market by Value

3.4.4 The U.S. Retail Cannabidiol Market Forecast by Value

3.5 The U.S. Cannabidiol Market by Product

3.5.1 The U.S. Inhalable Cannabidiol Market by Value

3.5.2 The U.S. Inhalable Cannabidiol Market Forecast by Value

3.5.3 The U.S. Confection Cannabidiol Market by Value

3.5.4 The U.S. Confection Cannabidiol Market Forecast by Value

3.5.5 The U.S. Sublingual Cannabidiol Market by Value

3.5.6 The U.S. Sublingual Cannabidiol Market Forecast by Value

3.5.7 The U.S. Wellness Cannabidiol Market by Value

3.5.8 The U.S. Wellness Cannabidiol Market Forecast by Value

3.5.9 The U.S. Beauty/Skin Cannabidiol Market by Value

3.5.10 The U.S. Beauty/Skin Cannabidiol Market Forecast by Value

3.5.11 The U.S. Food & Beverage Cannabidiol Market by Value

3.5.12 The U.S. Food & Beverage Cannabidiol Market Forecast by Value

3.5.13 The U.S. Supplements Cannabidiol Market by Value

3.5.14 The U.S. Supplements Cannabidiol Market Forecast by Value

3.5.15 The U.S. Pet Care Cannabidiol Market by Value

3.5.16 The U.S. Pet Care Cannabidiol Market Forecast by Value

3.5.17 The U.S. Pharmaceuticals Cannabidiol Market by Value

3.5.18 The U.S. Pharmaceuticals Cannabidiol Market Forecast by Value

4. Market Dynamics

4.1 Growth Drivers

4.1.1 Growing Incidence of Alzheimer’s Disease

4.1.2 Upsurge in Healthcare Expenditure

4.1.3 Rising Depression Rate

4.1.4 Increasing Geriatric Population

4.1.5 Expanding Urbanization

4.1.6 Approval of Cannabidiol based mostly Medication

4.1.7 Mounting Online Retail Sales

4.2 Key Trends & Developments

4.2.1 Increasing Prevalence of Arthritis

4.2.2 Rising Adoption amongst Millennials

4.2.3 Surging Occurrence of Chronic Disorders

4.2.4 Upswing in Sports Injuries

4.3 Challenges

4.3.1 High Cost of CBD Products

4.3.2 Side Effects Associated with CBD Products

4.3.3 Complex Regulatory Structure

5. Competitive Landscape

5.1 The U.S. Market

5.1.1 Revenue Comparison of Key Players

5.1.2 Market Capitalization Comparison of Key Players

5.1.Three R&D Comparison of Key Players

6. Company Profiles

6.1 Business Overview

6.2 Financial Overview

6.3 Business Strategies

  • Aphria Inc.
  • Aurora Cannabis Inc.
  • Canopy Growth Corporation
  • Charlotte’s Web Holdings Inc.
  • CV Sciences Inc.
  • Medical Marijuana, Inc.

For extra details about this report go to https://www.researchandmarkets.com/r/8i3uhv

Source link